Clinical Outcomes of Matched Unrelated Allogeneic Stem Cell Transplant Patients: Low Dose ATG vs. No ATG

Biology of Blood and Marrow Transplantation - Netherlands
doi 10.1016/j.bbmt.2018.12.226
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Allogeneic Hematopoietic Stem Cell Transplant Outcomes in Patients With Acute Erythroleukemia

Biology of Blood and Marrow Transplantation
TransplantationHematology
2016English

No Association Between Donor Telomere Length and Outcomes After Allogeneic Unrelated Hematopoietic Cell Transplant in Patients With Acute Leukemia

Bone Marrow Transplantation
TransplantationHematology
2017English

Empiric Anti-Thymocyte Globulin (ATG) Dosing in Ex-Vivo CD34-Selected Myeloablative Allogeneic Hematopoietic Cell Transplantation (Allo-Hct) May Result in ATG Overexposure That Negatively Affects Outcomes

Biology of Blood and Marrow Transplantation
TransplantationHematology
2018English

ATG Deadlines

Against the Grain
2013English

ATG Deadlines

Against the Grain
2016English

ATG Luminaries

Against the Grain
2016English

ATG Interview

Against the Grain
2013English

ATG Deadlines

Against the Grain
2014English

Alpha/Beta T-Cell Depleted Allogeneic Stem Cell Transplantation From Matched Related and Unrelated Donor Grafts in Patients With Poor Risk Leukemia

Biology of Blood and Marrow Transplantation
TransplantationHematology
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy